Advertisement

Topics

Samsung Bioepis Co., Ltd. Company Profile

08:38 EDT 27th March 2017 | BioPortfolio

Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to increasing patient access to affordable, high-quality biologic medicines. Through innovations in product development and quality assurance, Samsung Bioepis aims to become the world's leading biopharmaceutical company. Samsung Bioepis is a joint venture between Samsung BioLogics and Biogen. For more information, please visit: www.samsungbioepis.com.


News Articles [185 Associated News Articles listed on BioPortfolio]

Catalent to work with Samsung Bioepis on biosim production

Global CMO Catalent will help Samsung Bioepis supply its Enbrel biosimilar in Europe, where it is marketed by Biogen. 

Samsung Bioepis contracts Catalent to help commercialize Benepali

Samsung Bioepis has contracted Catalent to provide fill finish services for its Enbrel (etanercept) biosimilar, Benepali.

VIDEO: Bibila reviews Merck's biosimilar accomplishments

WASHINGTON — At the American College of Rheumatology Annual Meeting, Dora Bibila PhD, general manager of biosimilars at Merck, reviewed the company’s accomplishments with biosimilars.Through biosi...

Samsung Biologics Raises $2 Billion in Korean IPO

Samsung Biologics completed a $2 billion IPO in South Korea at an $8 billion valuation. The company, a division of the large Samsung semiconductor conglomerate, has two divisions: a biologics contract...

Benepali gains approval for extra indications

Samsung Bioepis, which is a joint venture between South Korean electronics giant Samsung and biotechnology company Biogen, announced on 16 December 2016 that the European Medicines Agency’s (EMA) Co...

Samsung Bioepis??? Type II Variation Application For Indication Extension Of Benepali Receives Positive Opinion

  Life Sciences Jobs   ...

Catalent to provide fill and finish services for commercial supply of Samsung Bioepis biosimilar therapy

Prefilled syringes to be produced at Brussels, Belgium facility

Samsung Bioepis in front row as lights near green on Humira biosimilars in Europe

When a UK High Court judge handed down a judgement to clear the route to market for biosimilar versions…

Drugs and Medications [0 Results]

None

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Clinical outcomes of tissue expanders on adjuvant radiotherapy of resected retroperitoneal sarcoma.

We investigated the efficacy and safety of a tissue expander (TE) for adjuvant radiotherapy (RT) of resected retroperitoneal sarcoma (RPS).This study was conducted with 37 patients with RPS who receiv...

Measuring the operational efficiency of individual theme park attractions.

This study assesses the operation efficiency of theme park attractions using the data envelopment analysis, utilizing actual data on 15 attractions at Samsung Everland located in Yongin-si, Republic o...

Tissue expander placement and adjuvant radiotherapy after surgical resection of retroperitoneal liposarcoma offers improved local control.

Given that retroperitoneal liposarcoma (LPS) is extremely difficult to completely resect, and has a relatively high rate of recurrence, radiotherapy (RT) is the treatment of choice after surgical rese...

Tissue expander placement and adjuvant radiotherapy after surgical resection of retroperitoneal liposarcoma offers improved local control.

Given that retroperitoneal liposarcoma (LPS) is extremely difficult to completely resect, and has a relatively high rate of recurrence, radiotherapy (RT) is the treatment of choice after surgical rese...

Conditional disease-free survival among patients with breast cancer.

Conditional disease-free survival (CDFS) reflects changes over time. Because traditional disease-free survival (DFS) is estimated from the date of diagnosis, it is limited in the ability to predict ri...

Clinical Trials [13 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting

To establish the performance characteristics of the Samsung LABGEO IVD-A20 CHF Test in intended use settings, by comparing test results of the A20 CHF Test with results obtained from an FD...

Gait Pattern Analysis and Feasibility of Gait Training With a Walking Assist Robot in Stroke Patients and Elderly Adults

The purpose of this study was to investigate the effects of the new wearable hip assist robot developed by Samsung Advanced Institute of Technology (Samsung Electronics Co, Ltd., Korea) to...

The Effect of a Walking Assist Robot on Gait Function and Brain Activity in Stroke Patients and Elderly Adults

The purpose of this study was to investigate the effects of the new wearable hip assist robot, gait enhancing mechatronic system (GEMS) developed by Samsung Advanced Institute of Technolog...

Samsung Medical Center-Lymphoma Cohort Study

The purpose of this study is to establish a model which can predict the treatment outcome and the risk of treatment-related morbidity in patients with lymphoma.

Database of Pelvic Inflammatory Disease

The aim of this prospective study is to collect data on in-patients with pelvic inflammatory disease(PID) at Kangbuk Samsung Hospital.

Companies [22 Associated Companies listed on BioPortfolio]

Samsung Bioepis Co., Ltd.

Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to increasing patient access to affordable, high-quality biologic medicines. Through innovations in p...

Samsung Electronics America

Samsung Electronics America, Inc. (SEA), based in Ridgefield Park, NJ, is a subsidiary of Samsung Electronics Co., Ltd. The company markets a broad range of award-winning consumer...

Samsung Electronics North America

Samsung Electronics North America (NAHQ), based in Ridgefield Park, NJ, is an arm of Samsung Electronics Co., Ltd. The company markets a broad range of award-winning consumer elec...

Samsung Electronics America, Inc.

Samsung Electronics America, Inc. (SEA), based in Ridgefield Park, NJ, is a subsidiary of Samsung Electronics Co., Ltd. The company markets a broad range of award-winning consumer...

Samsung Electronics America Inc.

As a global leader in Information Technology, Samsung’s Enterprise Business Division (EBD) is committed to introducing new business experiences across a diverse spectrum of i...

More Information about "Samsung Bioepis Co., Ltd." on BioPortfolio

We have published hundreds of Samsung Bioepis Co., Ltd. news stories on BioPortfolio along with dozens of Samsung Bioepis Co., Ltd. Clinical Trials and PubMed Articles about Samsung Bioepis Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Samsung Bioepis Co., Ltd. Companies in our database. You can also find out about relevant Samsung Bioepis Co., Ltd. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record